Coronary microvascular disease: the next frontier for Cardiovascular Research.
作者信息
Berry Colin, Duncker Dirk J
机构信息
British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
Department of Cardiology, Golden Jubilee National Hospital, Clydebank, UK.
出版信息
Cardiovasc Res. 2020 Mar 1;116(4):737-740. doi: 10.1093/cvr/cvaa035.
Abstract
摘要
相似文献
1
Coronary microvascular disease: the next frontier for Cardiovascular Research.冠状动脉微血管疾病：心血管研究的下一个前沿领域。
Cardiovasc Res. 2020 Mar 1;116(4):737-740. doi: 10.1093/cvr/cvaa035.
2
Experimental animal models of coronary microvascular dysfunction.冠状动脉微血管功能障碍的实验动物模型。
Cardiovasc Res. 2020 Mar 1;116(4):756-770. doi: 10.1093/cvr/cvaa002.
3
Coronary Microvascular Dysfunction.冠状动脉微血管功能障碍。
Arterioscler Thromb Vasc Biol. 2021 May 5;41(5):1625-1637. doi: 10.1161/ATVBAHA.121.316025. Epub 2021 Mar 25.
4
Reply: Microvascular Function in Ischemic Heart Disease: There May Be Room for Improvement.回复：缺血性心脏病中的微血管功能：或许仍有改善空间。
JACC Cardiovasc Interv. 2016 Feb 22;9(4):393. doi: 10.1016/j.jcin.2015.11.029.
5
Low Incidence of Diabetes Mellitus in Coronary Microvascular Dysfunction: An Intriguing Association.冠状动脉微血管功能障碍中糖尿病的低发病率：一种有趣的关联。
JACC Cardiovasc Interv. 2016 Feb 22;9(4):395-396. doi: 10.1016/j.jcin.2015.11.017. Epub 2016 Jan 6.
6
Microvascular Function in Ischemic Heart Disease: There May Be Room for Improvement.缺血性心脏病中的微血管功能：仍有改善空间。
JACC Cardiovasc Interv. 2016 Feb 22;9(4):392-393. doi: 10.1016/j.jcin.2015.10.041. Epub 2016 Jan 6.
7
Reply: Low Incidence of Diabetes Mellitus in Coronary Microvascular Dysfunction: An Intriguing Association.回复：冠状动脉微血管功能障碍中糖尿病的低发病率：一种有趣的关联。
JACC Cardiovasc Interv. 2016 Feb 22;9(4):396. doi: 10.1016/j.jcin.2015.12.005.
8
Reply: Microvascular Function in Ischemic Heart Disease: There May Be Room for Improvement.回复：缺血性心脏病中的微血管功能：或许仍有改善空间。
JACC Cardiovasc Interv. 2016 Feb 22;9(4):393-394. doi: 10.1016/j.jcin.2015.12.017.
9
Coronary microvascular dysfunction after ST-segment-elevation myocardial infarction: local or global phenomenon?ST段抬高型心肌梗死后的冠状动脉微血管功能障碍：局部还是整体现象？
Circ Cardiovasc Interv. 2013 Jun;6(3):201-3. doi: 10.1161/CIRCINTERVENTIONS.113.000462.
10
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.ESC 工作组关于“心血管疾病中的冠状动脉微血管功能障碍”的冠状动脉病理生理学和微循环立场文件
Cardiovasc Res. 2020 Mar 1;116(4):741-755. doi: 10.1093/cvr/cvaa003.
引用本文的文献
1
Oxygen-ozone therapy for myocardial ischemic stroke and cardiovascular disorders.臭氧氧气疗法治疗心肌缺血性中风和心血管疾病。
Med Gas Res. 2025 Mar 1;15(1):36-43. doi: 10.4103/mgr.MEDGASRES-D-23-00013. Epub 2024 Aug 31.
2
Transcriptomic and spatial dissection of human ex vivo right atrial tissue reveals proinflammatory microvascular changes in ischemic heart disease.人类离体右心房组织的转录组和空间解析揭示了缺血性心脏病中的促炎微血管变化。
Cell Rep Med. 2024 May 21;5(5):101556. doi: 10.1016/j.xcrm.2024.101556.
3
Vascularized hiPSC-derived 3D cardiac microtissue on chip.血管化 hiPSC 来源的 3D 心脏微组织芯片。
Stem Cell Reports. 2023 Jul 11;18(7):1394-1404. doi: 10.1016/j.stemcr.2023.06.001. Epub 2023 Jun 29.
4
Global trend and future landscape of coronary microcirculation: A bibliometric and visualized analysis from 1990 to 2021.冠状动脉微循环的全球趋势与未来前景：1990年至2021年的文献计量与可视化分析
Heliyon. 2023 Mar 28;9(4):e14894. doi: 10.1016/j.heliyon.2023.e14894. eCollection 2023 Apr.
5
Functional microvascularization of human myocardium .人类心肌的功能性微血管化。
Cell Rep Methods. 2022 Aug 29;2(9):100280. doi: 10.1016/j.crmeth.2022.100280. eCollection 2022 Sep 19.
6
Doppler Echocardiography Assessment of Coronary Microvascular Function in Patients With Angina and No Obstructive Coronary Artery Disease.心绞痛且无阻塞性冠状动脉疾病患者冠状动脉微血管功能的多普勒超声心动图评估
Front Cardiovasc Med. 2021 Oct 29;8:723542. doi: 10.3389/fcvm.2021.723542. eCollection 2021.
7
Reduced nitric oxide bioavailability impairs myocardial oxygen balance during exercise in swine with multiple risk factors.多种危险因素致猪运动时一氧化氮生物利用度降低，心肌氧平衡受损。
Basic Res Cardiol. 2021 Aug 26;116(1):50. doi: 10.1007/s00395-021-00890-8.
8
Human coronary microvascular contractile dysfunction associates with viable synthetic smooth muscle cells.人类冠状动脉微血管收缩功能障碍与有活力的合成平滑肌细胞有关。
Cardiovasc Res. 2022 Jun 29;118(8):1978-1992. doi: 10.1093/cvr/cvab218.
9
Vascularisation of pluripotent stem cell-derived myocardium: biomechanical insights for physiological relevance in cardiac tissue engineering.多能干细胞衍生心肌的血管化：心脏组织工程中生理相关性的生物力学见解。
Pflugers Arch. 2021 Jul;473(7):1117-1136. doi: 10.1007/s00424-021-02557-8. Epub 2021 Apr 14.
本文引用的文献
1
Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses.联合压力和流量测量以指导冠状动脉狭窄的治疗。
JACC Cardiovasc Interv. 2021 Sep 13;14(17):1904-1913. doi: 10.1016/j.jcin.2021.07.041.
2
Treatment of coronary microvascular dysfunction.冠状动脉微血管功能障碍的治疗。
Cardiovasc Res. 2020 Mar 1;116(4):856-870. doi: 10.1093/cvr/cvaa006.
3
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.ESC 工作组关于“心血管疾病中的冠状动脉微血管功能障碍”的冠状动脉病理生理学和微循环立场文件
Cardiovasc Res. 2020 Mar 1;116(4):741-755. doi: 10.1093/cvr/cvaa003.
4
Coronary microvascular dysfunction in hypertrophy and heart failure.肥厚型心肌病和心力衰竭中的冠状动脉微血管功能障碍。
Cardiovasc Res. 2020 Mar 1;116(4):806-816. doi: 10.1093/cvr/cvaa023.
5
The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions.在其他心脏或全身情况的背景下，冠状动脉微血管功能障碍的致病作用。
Cardiovasc Res. 2020 Mar 1;116(4):817-828. doi: 10.1093/cvr/cvaa009.
6
Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction.内皮素-1的基因失调与冠状动脉微血管功能障碍有关。
Eur Heart J. 2020 Sep 7;41(34):3239-3252. doi: 10.1093/eurheartj/ehz915.
7
Sex differences in non-obstructive coronary artery disease.非阻塞性冠状动脉疾病中的性别差异。
Cardiovasc Res. 2020 Mar 1;116(4):829-840. doi: 10.1093/cvr/cvaa001.
8
Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease).稳定型缺血性心脏病（非阻塞性冠状动脉疾病和阻塞性冠状动脉疾病）中的冠状动脉微血管功能障碍。
Cardiovasc Res. 2020 Mar 1;116(4):771-786. doi: 10.1093/cvr/cvaa005.
9
Experimental animal models of coronary microvascular dysfunction.冠状动脉微血管功能障碍的实验动物模型。
Cardiovasc Res. 2020 Mar 1;116(4):756-770. doi: 10.1093/cvr/cvaa002.
10
Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study.英国心脏基金会（BHF）冠状动脉微血管功能和 CT 冠状动脉成像（CorCTCA）研究的原理和设计。
Am Heart J. 2020 Mar;221:48-59. doi: 10.1016/j.ahj.2019.11.015. Epub 2019 Dec 2.
Zotero 插件